Deutsche Märkte geschlossen

Cencora, Inc. (0HF3.L)

LSE - LSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
241,08-3,02 (-1,24%)
Börsenschluss: 06:03PM GMT

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

Sektor(en)
Branche
Vollzeitmitarbeiter42.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Steven H. CollisChairman, President & CEO5,01M13,79M1961
Mr. James F. Cleary Jr.Executive VP & CFO1,95M3,8M1963
Dr. Robert P. Mauch Ph.D., PharmDExecutive VP & COO2,7MN/A1967
Ms. Gina K. ClarkExecutive VP and Chief Communications & Administration Officer1,57M5,01M1957
Ms. Elizabeth S. CampbellExecutive VP & Chief Legal Officer1,63M318,67k1975
Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate ControllerN/AN/A1965
Bennett S. MurphySenior Vice President of Investor RelationsN/AN/AN/A
Ms. Jennifer E. DubasSenior VP & Chief Compliance OfficerN/AN/AN/A
Ms. Silvana BattagliaExecutive VP & Chief Human Resources Officer1,58MN/A1968
Ms. Leslie E. DonatoExecutive VP & Chief Strategy OfficerN/AN/A1970
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Corporate Governance

Cencora, Inc.s ISS Governance QualityScore, Stand 1. März 2024, lautet 3. Die grundlegenden Scores sind Audit: 2, Vorstand: 5, Shareholderrechte: 7, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.